Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
673 JPY | -2.04% | -2.32% | -6.01% |
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The firm trades with high earnings multiples: 25.67 times its 2024 earnings per share.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.01% | 94.69M | - | ||
+22.48% | 413B | B | ||
+13.33% | 238B | D+ | ||
+10.10% | 141B | A- | ||
+14.68% | 99.21B | C- | ||
+16.77% | 83.41B | B+ | ||
+51.42% | 56.64B | B- | ||
+28.81% | 51.49B | C+ | ||
+3.40% | 36.9B | B | ||
+15.33% | 34.27B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6095 Stock
- Ratings MedPeer,Inc.